{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311818/35550/de/XBiotech-startet-klinische-Phase-II-Studie-zur-Bewertung-von-Vilamakitug-bei-der-Behandlung-der-aktiven-axialen-Spondyloarthritis.html", "message": "News view counter 798976 successfully enlarged"}